Intellectual developmental disorder with hypertelorism and distinctive facies (IDDHDF) A case study with literature review

Kimseang Nget; Zhu Min

doi:10.59653/jhsmt.v2i02.666

Authors

Kimseang Nget Nanjing Medical University
Zhu Min Nanjing Medical University

DOI:

https://doi.org/10.59653/jhsmt.v2i02.666

Keywords:

Neurodevelopment deviations, Distinctive facial feature, CCNK gene mutation

Abstract

The research aims to investigate the clinical manifestations of neurodevelopmental problems in children with different facies and CCNK gene mutant characteristics. A literature study was carried out to identify the role of CCNK mutations in IDDHDF. Chinese and international search engines like PubMed, MEDLINE, Wanfang Data Knowledge, and Google Scholar were used to search. The search phrases "CCNK", "intellectual developmental disorder", "hypertelorism", and "distinctive facies" were used. A total of 5 studies were found, 11 cases were presented, 3 were thoroughly discussed, and 1 case was presented in this study. The clinical signs and genetic characteristics of children with intellectual developmental disorders with hypertelorism and unique facies were summarized. A male child was 1 year 4 months old. Last 1 year, he appeared of motor and cognitive lag, unable to crawl or stand. He had a large forehead head, wide eye spacing, and cognitive deficiencies, and he was clinically diagnosed with global developmental delay. C.437(exon5) T>C was not found in any of the child's parents and represents a de novo mutation. The main clinical signs were impairments in intellectual development, wide eye spacing, and facial feature features. The findings of the studies discussed here imply that mutations in the CCNK gene may cause IDDHDF. This is a very new kind of study in China to uncover the clinical aspects of a case of Intellectual developmental disorder with hypertelorism and distinctive facies (IDDF). It's discovered that wild-type mRNA coding CCNK partially repaired early defects but not the mRNA with the identified likely pathogenic variation c.331A>G. This shows that CCNK variations are involved in IDDF. The researchers also discovered that the likely pathogenic mutation c.331A>G may induce IDDF via a haploinsufficiency mechanism.

Downloads

Download data is not yet available.

References

Araki, S., Ohori, M., & Yugami, M. (2023). Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities. In Frontiers in Oncology (Vol. 13). https://doi.org/10.3389/fonc.2023.1152087

Coppine, J., Kaczmarczyk, A., Petit, K., Brochier, T., Jenal, U., & Hallez, R. (2020). Regulation of bacterial cell cycle progression by redundant phosphatases. Journal of Bacteriology, 202(17). https://doi.org/10.1128/JB.00345-20

Dai, W., Wang, H., Zhan, Y., Li, N., Li, F., Wang, J., Yan, H., Zhang, Y., Wang, J., Wu, L., Liu, H., Fan, Y., Tao, Y., Mo, X., Yang, J. J., Sun, K., Chen, G., & Yu, Y. (2023). CCNK Gene Deficiency Influences Neural Progenitor Cells Via Wnt5a Signaling in CCNK-Related Syndrome. Annals of Neurology, 94(6). https://doi.org/10.1002/ana.26766

Elmasry, G. F. (2023). Cyclin-dependent kinase 2 (CDK2). In Metalloenzymes: From Bench to Bedside. https://doi.org/10.1016/B978-0-12-823974-2.00030-9

Fan, J., Rosenfeld, D., Zhang, Y., Giangrande, S. E., Li, Z., Machado, L. A. T., Martin, S. T., Yang, Y., Wang, J., Artaxo, P., Barbosa, H. M. J., Braga, R. C., Comstock, J. M., Feng, Z., Gao, W., Gomes, H. B., Mei, F., Pöhlker, C., Pöhlker, M. L., … De Souza, R. A. F. (2018). Substantial convection and precipitation enhancements by ultrafine aerosol particles. Science, 359(6374). https://doi.org/10.1126/science.aan8461

Fan, Y., Yin, W., Hu, B., Kline, A. D., Zhang, V. W., Liang, D., Sun, Y., Wang, L., Tang, S., Powis, Z., Li, L., Yan, H., Shi, Z., Yang, X., Chen, Y., Wang, J., Jiang, Y., Tan, H., Gu, X., … Yu, Y. (2018). De Novo Mutations of CCNK Cause a Syndromic Neurodevelopmental Disorder with Distinctive Facial Dysmorphism. American Journal of Human Genetics, 103(3). https://doi.org/10.1016/j.ajhg.2018.07.019

Insco, M. L., Abraham, B. J., Dubbury, S. J., Kaltheuner, I. H., Dust, S., Wu, C., Chen, K. Y., Liu, D., Bellaousov, S., Cox, A. M., Martin, B. J. E., Zhang, T., Ludwig, C. G., Fabo, T., Modhurima, R., Esgdaille, D. E., Henriques, T., Brown, K. M., Chanock, S. J., … Zon, L. I. (2023). Oncogenic CDK13 mutations impede nuclear RNA surveillance. Science, 380(6642). https://doi.org/10.1126/science.abn7625

Maity, T. K., Kim, E. Y., Cultraro, C. M., Venugopalan, A., Khare, L., Poddutoori, R., Marappan, S., Syed, S. D., Telford, W. G., Samajdar, S., Ramachandra, M., & Guha, U. (2023). Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance. Cancers, 15(8). https://doi.org/10.3390/cancers15082263

Malumbres, M. (2014). Cyclin-dependent kinases. Genome Biology, 15(6). https://doi.org/10.1186/gb4184

Ruiz-Reig, N., Hakanen, J., & Tissir, F. (2024). Connecting neurodevelopment to neurodegeneration: A spotlight on the role of kinesin superfamily protein 2A (KIF2A). In Neural Regeneration Research (Vol. 19, Issue 2). https://doi.org/10.4103/1673-5374.375298

Sabariego-Navarro, M., Fernández-Blanco, Á., Sierra, C., & Dierssen, M. (2022). Neurodevelopmental disorders: 2022 update. In Free Neuropathology (Vol. 3). https://doi.org/10.17879/freeneuropathology-2022-3801

Wang, H., Fan, Z., Shliaha, P. V., Miele, M., Hendrickson, R. C., Jiang, X., & Helin, K. (2023). H3K4me3 regulates RNA polymerase II promoter-proximal pause-release. Nature, 615(7951). https://doi.org/10.1038/s41586-023-05780-8

Yu, Z., Teng, Y., Yang, J., & Yang, L. (2024). The role of exosomes in adult neurogenesis: Implications for neurodegenerative diseases. In Neural Regeneration Research (Vol. 19, Issue 2). https://doi.org/10.4103/1673-5374.379036

Zamora‐moratalla, A., de Lagrán, M. M., & Dierssen, M. (2021). Neurodevelopmental disorders: 2021 update. In Free Neuropathology (Vol. 2). https://doi.org/10.17879/freeneuropathology-2021-3268